Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
- PMID: 26848401
- PMCID: PMC4731834
- DOI: 10.1136/rmdopen-2015-000161
Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
Abstract
Objective: To identify which laboratory tests that change over time are most valuable for the timely diagnosis of macrophage activation syndrome (MAS) complicating systemic juvenile idiopathic arthritis (sJIA).
Methods: A multistep process, based on a combination of expert consensus and analysis of real patient data, was conducted. A panel of experts was first asked to evaluate 115 profiles of patients with MAS, which included the values of laboratory tests at the pre-MAS visit and at MAS onset, and the change in values between the two time points. The experts were asked to choose the 5 laboratory tests in which change was most important for the diagnosis of MAS and to rank the 5 selected tests in order of importance. The relevance of change in laboratory parameters was further discussed and ranked by the same experts at a consensus conference.
Results: Platelet count was the most frequently selected test, followed by ferritin level, aspartate aminotransferase (AST), white cell count, neutrophil count, and fibrinogen and erythrocyte sedimentation rate. Ferritin was most frequently assigned the highest score. At the end of the process, platelet count, ferritin level and AST were the laboratory tests in which the experts found change over time to be most important.
Conclusions: We identified the laboratory tests in which change over time is most valuable for the early diagnosis of MAS in sJIA. The dynamics of laboratory values during the course of MAS should be further scrutinised in a prospective study in order to establish the optimal cut-off values for their variation.
Keywords: Epidemiology; Juvenile Idiopathic Arthritis; Outcomes research.
Similar articles
-
Single center clinical analysis of macrophage activation syndrome complicating juvenile rheumatic diseases.Pediatr Rheumatol Online J. 2024 May 23;22(1):58. doi: 10.1186/s12969-024-00991-3. Pediatr Rheumatol Online J. 2024. PMID: 38783316 Free PMC article.
-
Characterization of Patients with Macrophage Activation Syndrome Secondary to Systemic Juvenile Idiopathic Arthritis.Clin Rheumatol. 2025 May;44(5):2023-2029. doi: 10.1007/s10067-025-07420-0. Epub 2025 Mar 27. Clin Rheumatol. 2025. PMID: 40146446
-
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.Arthritis Rheumatol. 2016 Mar;68(3):566-76. doi: 10.1002/art.39332. Epub 2016 Feb 9. Arthritis Rheumatol. 2016. PMID: 26314788
-
Is it possible to predict a disease course prone to macrophage activation syndrome at systemic juvenile idiopathic arthritis diagnosis?Clin Rheumatol. 2024 Jan;43(1):415-421. doi: 10.1007/s10067-023-06828-w. Epub 2023 Nov 28. Clin Rheumatol. 2024. PMID: 38012469
-
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.Ann Rheum Dis. 2016 Mar;75(3):481-9. doi: 10.1136/annrheumdis-2015-208982. Ann Rheum Dis. 2016. PMID: 26865703
Cited by
-
Juvenile idiopathic arthritis.Nat Rev Dis Primers. 2022 Jan 27;8(1):5. doi: 10.1038/s41572-021-00332-8. Nat Rev Dis Primers. 2022. PMID: 35087087 Review.
-
Cytokine Storm Syndrome Associated with Systemic Juvenile Idiopathic Arthritis.Adv Exp Med Biol. 2024;1448:323-353. doi: 10.1007/978-3-031-59815-9_23. Adv Exp Med Biol. 2024. PMID: 39117825 Review.
-
[Focus on pediatric rheumatic and immune diseases].Zhejiang Da Xue Xue Bao Yi Xue Ban. 2018 May 25;47(2):213-217. doi: 10.3785/j.issn.1008-9292.2018.04.17. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2018. PMID: 30226319 Free PMC article. Chinese. No abstract available.
-
Biomarkers in Systemic Juvenile Idiopathic Arthritis, Macrophage Activation Syndrome and Their Importance in COVID Era.Int J Mol Sci. 2022 Oct 22;23(21):12757. doi: 10.3390/ijms232112757. Int J Mol Sci. 2022. PMID: 36361547 Free PMC article. Review.
-
Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Childhood Inflammatory Disorders: Diagnosis and Management.Paediatr Drugs. 2020 Feb;22(1):29-44. doi: 10.1007/s40272-019-00367-1. Paediatr Drugs. 2020. PMID: 31732958 Free PMC article. Review.
References
-
- Prieur AM, Stephan JL. [Macrophage activation syndrome in rheumatic diseases in children]. Rev Rhum Ed Fr 1994;61:447–51. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources